Targeting BTK in B-Cell Malignancies

preview_player
Показать описание
An understanding of Bruton tyrosine kinase (BTK) and the rationale for targeting the B-cell receptor signaling pathway in certain B-cell malignancies.
  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
Targeting BTK in 0:03:53

Targeting BTK in B-Cell Malignancies

Identifying Differences Between 0:01:00

Identifying Differences Between BTK Inhibitors for B-Cell Malignancies

Targeting BTK and 0:21:28

Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?

Dr. Ma on 0:01:45

Dr. Ma on First- and Second-Generation BTK Inhibitors in B-Cell Malignancies

Comparing BTK Inhibitors 0:01:01

Comparing BTK Inhibitors in Patients With B-Cell Malignancies

Resistance to BTK 0:03:41

Resistance to BTK Inhibitors in B-Cell Malignancies

BTK Combination Strategies 0:05:49

BTK Combination Strategies for B-Cell Malignancies

Exploring Questions Remaining 0:01:27

Exploring Questions Remaining for BTK Inhibitors and B-Cell Malignancies

BTK Inhibitors Explored 0:04:40

BTK Inhibitors Explored in B-Cell Malignancies

Targeting B-Cell Receptor 0:02:14

Targeting B-Cell Receptor Signaling for Anticancer Therapy

Progress With BTK 0:22:36

Progress With BTK Inhibitors: A Journey Through the Mechanisms of Covalent and Noncovalent Options

Dr. Leslie on 0:01:00

Dr. Leslie on the Utility of BTK Inhibitors in B-Cell Malignancies

BTK Inhibitors and 0:07:59

BTK Inhibitors and Toxicity Management in B-Cell Lymphomas

discovery of NX-2127, 0:16:22

discovery of NX-2127, a BTK degrader for B-cell malignancies

Solving the Puzzles 1:32:21

Solving the Puzzles for B-Cell Malignancies: Navigating the Place of BTK Inhibitors Today and Tom...

Improving on the 0:39:22

Improving on the Past: Using Next-Generation BTK Inhibitors Effectively in B-Cell Malignancies

Dr. Furman on 0:01:05

Dr. Furman on Differences Between BTK Inhibitors in B-Cell Malignancies

The Future of 0:07:17

The Future of BTK Inhibition in B-Cell Lymphomas

Alexey Danilov, ASH 0:06:21

Alexey Danilov, ASH 2019: Advancing the Role of BTK Inhibitors in B-Cell Malignancies

B-Cell Malignancies: Why 0:46:31

B-Cell Malignancies: Why Not All BTK Inhibitors Are Created Equal

Dr. Ghosh on 0:00:54

Dr. Ghosh on Approved BTK Inhibitors in B-Cell Malignancies

BTK Inhibitors as 0:05:44

BTK Inhibitors as Treatment for B-Cell Lymphomas

LOXO-35: a next 0:01:54

LOXO-35: a next gen BTK inhibitor for B-cell malignancies

TG-1701: a BTK 0:04:25

TG-1701: a BTK inhibitor for B-cell malignancies